List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 122 studies with search of: "Thrombocytosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
Conditions: Polycythemia Vera;   Essential Thrombocytosis
Intervention: Drug: lestaurtinib
2 Recruiting Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
Conditions: Thrombocytosis;   Iron Deficiency
Interventions: Drug: Ferinject;   Drug: Placebo
3 Recruiting Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Conditions: Myelofibrosis;   Polycythemia Vera;   Thrombocytosis
Intervention:
4 Recruiting A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: HDAC inhibitor (MK-0683)
5 Recruiting Primary Thrombocythaemia 1 Trial
Conditions: Thrombocythemia;   Myeloproliferative Disorder
Interventions: Drug: Hydroxyurea;   Drug: Aspirin
6 Recruiting Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Myelofibrosis
Intervention:
7 Active, not recruiting Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Interventions: Drug: INCB018424;   Drug: INCB018424;   Drug: INCB018424
8 Recruiting A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients
Condition: Thrombocythemia, Hemorrhagic
Interventions: Drug: Anagrelide;   Drug: Hydroxyurea
9 Recruiting Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other Treatments
Condition: Thrombocythemia, Essential
Intervention:
10 Recruiting Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocytosis;   Idiopathic Myelofibrosis;   Neutrophils;   Chronic Myeloproliferative Disorders
Intervention:
11 Completed A Phase II Study of the Pharmacokinetics of Anagrelide in Elderly and Young ET Patients
Condition: Essential Thrombocythaemia
Intervention: Drug: anagrelide hydrochloride
12 Recruiting CEP-701 (Lestaurtinib) in Myelofibrosis
Conditions: Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention: Drug: CEP-701 (Lestaurtinib)
13 Recruiting Research Tissue Bank
Conditions: Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
14 Recruiting A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
Conditions: Myelofibrosis;   Myeloproliferative Disorders;   Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: SB1518
15 Recruiting Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disease;   Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
16 Recruiting Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Idiopathic Myelofibrosis
Intervention:
17 Suspended CC-4047 in Treating Patients With Polycythemia Vera or Essential Thrombocythemia and Myelofibrosis That Did Not Respond to Lenalidomide or Thalidomide
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders
Interventions: Drug: CC-4047;   Other: questionnaire administration
18 Active, not recruiting A Safety Study of XL019 in Adults With Myelofibrosis
Conditions: Myeloproliferative Disorders;   Myelofibrosis;   Polycythemia Vera;   Thrombocythemia, Essential
Intervention: Drug: XL019
19 Recruiting A Dose-Escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: TG101348
20 Completed Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lung Cancer;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: epoetin alfa;   Procedure: quality-of-life assessment

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services